Please assess the completion status of the following clinical trial:

Trial Title: Compartment Psoas Block Efficacy and Safety

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~-proximal femur fracture~Exclusion Criteria:~* pregnancy and lactation~* history of opiate addiction~* traumatic brain injury~* acute cerebrovascular accident~* chronic heart failure (New York Heart Association Functional Classification, NYHA, class III-IV)~* respiratory failure~* renal failure with decreased creatinine clearance less than 30 ml / min / 1.73 m2~* hepatic insufficiency class C according to Child-Pugh).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: EXPERIMENTAL): Patients in group 1 underwent catheterization of the lumbar plexus from the posterior access on admission to the hospital and began analgesia with bupivacaine 0.125% 6-8 ml / h. Intraoperative anaesthesia was provided with a bupivacaine bolus of 0.5% 200 mg in a lumbar catheter and a sciatic nerve block with 1.5% 450 mg of lidocaine. Postoperative analgesia was provided by an elongated lumbar plexus block with bupivacaine 0.125% 6-8 ml / h.
- Group 2 (Type: NO_INTERVENTION): Patients in group 2 underwent intraoperative spinal anaesthesia at the level of L3-L4 with hyperbaric bupivacaine at a dose of 10-15 mg.
- Group 3 (Type: NO_INTERVENTION): Group 3 patients underwent general inhalation anaesthesia with sevoflurane with a constant infusion of fentanyl for analgesia.

Based on this trial design, predict the completion outcome and termination type (if applicable).